Meldungen sortieren nach Relevanz Meldungsdatum
|
Evotec Q1 2013: Innovations-effizienz beschleunigen
, Forschung und Entwicklung, Evotec AG
. - STARKE STRATEGISCHE POSITION UNTERSTÜTZT DEN WEG FÜR INNOVATIONSEFFIZIENZ (AKTIONSPLAN 2016) - WIRKSTOFFFORSCHUNGSPLATTFORM GENERIERT WACHSTUM - NEUES HORMON...
|
Gas-Flüssig-Reaktionen mit besserer Kontrolle
, Medizintechnik, Uniqsis Ltd
Sygnature Discovery (Nottingham, UK), ein führender Anbieter von integrierten Drug Discovery-Lösungen für die pharmazeutische Industrie, hat kürzlich erste Ergebnisse...
|
All critical types of viral vectors now from one competent source, both ready-to-use and custom made
, Biotechnik, SIRION BIOTECH GmbH
SIRION Biotech has taken a critical step in the company's development towards a viral vector Center of Competence: all three major types of viral vectors used for...
|
A New EU-Funded Industry-Academia Drug Discovery Partnership Targets Challenging Kinases
, Forschung und Entwicklung, SARomics AB
SARomics Biostructures, Prestwick Chemical and ProQinase together with the University of Turin, Italy, the Israel Structural Proteomics Center (ISPC) at the Weizmann...
|
NovAliX and Inventiva Form a Strategic Alliance on Nuclear Receptors
, FirmenIntern, NovAliX
Inventiva and NovAliX announced today that they have entered into a strategic alliance dedicated to the discovery of clinical candidates, targeting nuclear receptors. After...
|
Proteros and Priaxon Announce Lead Discovery Collaboration on Protein-Protein Interaction Targets
, Biotechnik, Priaxon AG
Proteros biostructures GmbH ("Proteros") today announced that the company entered into a Lead Discovery Collaboration with Priaxon AG to jointly develop lead compounds...
|
Analysis of complex protein-protein-interactions made easy
ChromoTek GmbH (Munich, Germany) has developed a series of highly sensitive protein-protein-interaction (PPI) assays to screen compounds that resolve the binding...
|
Medicyte GmbH Signs Agreement with Life Technologies to Develop Next Generation Upcyte® Cells
, FirmenIntern, Medicyte GmbH
Medicyte has signed a licensing agreement for the rights to use Lentiviral vector technology from Life Technologies to develop and market next generation, cell-based...
|
Nuevolution Announces Formation of Strong Scientific Advisory Panel
, Forschung und Entwicklung, Nuevolution A/S
Nuevolution teams with key scientific advisors to assist the progression of its internal drug discovery programs within Inflammation and Oncology. In June 2012,...
|
|
Biomolecular movies: ChromoTek introduces Chromobody® plasmids for real time monitoring of key intracellular target molecules in vivo
ChromoTek GmbH (Munich, Germany) offers nanobody based real time assays to visualize and measure the action of candidate drugs or other substances of interest on...
|
4SC Discovery and BioNTech announce exclusive research and license agreement for 4SC's TLR agonists for cancer immunotherapy
, Forschung und Entwicklung, 4SC AG
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced...
|
Adeno-associated virus now easily available for research and preclinical studies.
, Biotechnik, PlasmidFactory GmbH & Co. KG
Munich, Bielefeld, Heidelberg (Germany), SIRION Biotech and PlasmidFactory agreed to actively promote adeno-associated virus (AAV) vectors for advanced preclinical...
|
QIAGEN gains SFDA approval to market careHPV Test in China - expanding access to HPV testing in low-resource countries
, Forschung und Entwicklung, QIAGEN GmbH
. - Commercial launch of careHPV in China and other emerging markets will enable high-quality screening for prevention of cervical cancer - "Country of Origin"...
|
MorphoSys und Lanthio Pharma unterzeichnen Technologiepartnerschaft für neue Klasse therapeutischer Peptide
, Medizintechnik, MorphoSys AG
Die MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) gab heute eine Kooperation mit dem privat geführten Biopharmazie-Unternehmen Lanthio Pharma bekannt,...
|
Nanion Introduces Platform-Certified Cell Lines
, Forschung und Entwicklung, Nanion Technologies GmbH
Nanion’s automated patch clamp platforms are known for their high cell compatibility, even for primary cells and stem cells. Nanion now introduces “Nanion Approved...
Firmen
Kategorien
- Forschung und Entwicklung (60)
- Kooperationen / Fusionen (32)
- Biotechnik (28)
- Medizintechnik (17)
- FirmenIntern (15)
Alle Kategorien
